Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are pregnant, Specialist Pharmacy Service (published 12th October 2021)

This page signposts to current guidance on this off-label use of the two medicines from the UK Royal College of Obstetricians and Gynaecologists and UKTIS. Healthcare professionals are encouraged to contact UKTIS should they be considered for use.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news